Free Trial

Amdocs Limited (NASDAQ:DOX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Amdocs logo with Computer and Technology background
Remove Ads

Amdocs Limited (NASDAQ:DOX - Get Free Report) has earned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $101.20.

DOX has been the topic of several recent analyst reports. Oppenheimer raised their price target on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a report on Wednesday, November 13th. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday. Finally, Barclays lowered their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th.

Check Out Our Latest Analysis on DOX

Hedge Funds Weigh In On Amdocs

Large investors have recently modified their holdings of the company. Alyeska Investment Group L.P. increased its stake in Amdocs by 86.8% in the 4th quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company's stock worth $143,127,000 after purchasing an additional 781,061 shares during the period. Pzena Investment Management LLC grew its stake in Amdocs by 12.3% in the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company's stock worth $556,700,000 after purchasing an additional 696,136 shares during the period. Wellington Management Group LLP grew its stake in Amdocs by 25.4% in the fourth quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after purchasing an additional 543,490 shares during the period. Raymond James Financial Inc. purchased a new stake in shares of Amdocs in the fourth quarter worth $44,494,000. Finally, Vanguard Group Inc. grew its stake in shares of Amdocs by 16.1% in the fourth quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after acquiring an additional 426,035 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Amdocs Stock Performance

Shares of DOX stock traded down $0.34 on Friday, hitting $86.48. 505,162 shares of the stock were exchanged, compared to its average volume of 663,058. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $9.76 billion, a PE ratio of 20.06, a P/E/G ratio of 1.47 and a beta of 0.71. Amdocs has a one year low of $74.41 and a one year high of $94.04. The firm's 50 day moving average is $86.21 and its two-hundred day moving average is $86.88.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Sell-side analysts expect that Amdocs will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.44%. This is a boost from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. Amdocs's dividend payout ratio (DPR) is currently 48.72%.

About Amdocs

(Get Free Report

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Further Reading

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads